Dear Members, dear Customers China-Italy Chamber of Commerce (CICC) asks for your valued opinion about CICC services. Please fill in the questionnaire.
Link to Survey
The China-Italy Chamber of Commerce, together with its Healthcare Working Group, the EU SME Centre and the European Union Chamber of Commerce in China, is pleased to invite you to the workshop "China's Healtcare Sector" which will take place on May 19th at 16:00 (China time).
The event will be held both online via Zoom and offline at the European Chamber Shanghai Office.
China’s healthcare industry has emerged as one of the fastest growing sectors in the country. A key driver of this growth is China’s rapidly aging population, which is creating higher demand for healthcare services, pharmaceuticals, and medical innovations.
What role can European SMEs play in this industry? How are regulations, procurement conditions, state-led initiatives and other factors shaping market access in practice? These are just some of the key questions that this workshop seeks to address.
AGENDA
16:00–16:05 Opening remarks
Liam Jia, Team Leader, EU SME Centre
16:05–16:25 Overview of China’s Healthcare Sector
Jens Ewert, National Leader Life Science Healthcare Industry, Deloitte
16:25–16:45 Registration Procedures for Medical Devices
Hamish King, CEO at Cisema
16:45–17:15 Panel Discussion: Market Access for European SMEs in the Healthcare Sector
Moderator: Valtero Canepa, General Manager at Bracco Sine Pharmaceutical Shanghai
17:15–17:30 Q&A session
REGISTRATION
To join the event please CLICK HERE
This event is free of charge - registration is mandatory
SPEAKERS
Jens Ewert, a Senior Partner with Deloitte China, has over 30 years of working experience in the professional services. Based in Shanghai since end 2002, he has been a member of Deloitte China Eastern Region Management team since then. Jens is the national leader for Deloitte China Life Science & Health Care Industry, leading a dedicated industry team comprising over 1000+ partners and professionals. He also covers our full range of multidisciplinary services, from consulting, risk & financial & tax advisory and audit & assurance, offering to multinational clients in China.
Hamish King, LLB, RAC is CEO at Cisema, a regulatory and compliance consultancy for China founded in Munich and Beijing in 2002. Cisema is a 100-strong family-owned company providing regulatory and compliance services, including product registration, in-China testing, clinical studies and writing, regulatory communications, local agent, post market surveillance, quality control and audits.
Valtero Canepa moved to China in 2013, where he General Manager of Bracco, an Italian Healthcare Group, specialised in contrast agents for diagnostic imaging and related medical devices. Mr Canepa manages the three Chinese companies of the Group (two affiliates and a JV), accounting for about 1.6 billion RMB and employing more than four hundred people, including R&D, business development, medical and regulatory, production, distribution, promotion, and sales. The largest among the three companies, BraccoSine, is presently expanding its presence in China, with the construction of a new production plan in Pudong (Shanghai), with an investment of more than 300 million RMB.
Jintao Yu is the Sales Director for Greater China at Copan Medical Shanghai, a wholly owned subsidiary of Copan Group Italy. With over 10 years of experience across multiple business functions, Jintao specializes in market access strategies and operational management in China. He has a strong background in building strategic partnerships, navigating regulatory environments, and supporting the localization of European products in the Chinese healthcare sector.
EVENT DETAILS
成为我们超过850个意大利及外国企业这个网络体系中的一员. 通过赞助商、合作以及在我们的官方网站上投放广告从而使您获得更高的知名度.
Copyright ©2016 by China-Italy Chamber of Commerce Website Maintenance China | flow.asia 京ICP备06006969号-1
成为我们超过500个意大利及外国企业这个网络体系中的一员. 通过赞助商、合作以及在我们的官方网站上投放广告从而使您获得更高的知名度。
